Jpmorgan Chase & CO Eton Pharmaceuticals, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 723 shares of ETON stock, worth $7,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
723Holding current value
$7,540% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ETON
# of Institutions
51Shares Held
9.44MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$29 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$10.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$10.4 Million0.36% of portfolio
-
Westside Investment Management, Inc.619KShares$6.45 Million0.79% of portfolio
-
Acuitas Investments, LLC580KShares$6.05 Million1.66% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $264M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...